Neoplasm Treatment - Guatemala
Guatemala- The Neoplasm Treatment market in Guatemala is expected to generate a revenue of US$198.60m by 2024.
- It is projected to experience a steady annual growth rate of 6.38% from 2024 to 2029, leading to a market volume of US$270.60m by 2029.
- When compared globally, United States is forecasted to generate the highest revenue in the Neoplasm Treatment market, with an estimated amount of US$90.56bn in 2024.
- In Guatemala, there is a growing trend towards the use of alternative and traditional medicine in neoplasm treatment.
Definition:
Neoplasm Treatment refers to the medical and surgical treatments of cancer patients who require hospitalization for their care. This includes surgeries, chemotherapy, radiation therapy, immunotherapy, and/or other treatments that require close monitoring and support from healthcare professionals. Patients will typically stay in a hospital for several days to several weeks, depending on the severity of their condition. This allows hospitals to provide the highest level of medical support and to help manage symptoms and/or side effects of the patients while they receive treatment.
Additional information:
The Neoplasm Treatments market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Inpatient treatment of cancer patients
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
